News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
La Inflamación Crónica
Chronic Inflammation: A Key Factor in the Threat to Healthy Aging and Healthy Living
Healthcare
Recent research links persistent inflammatory status to metabolic, neurodegenerative and…
Partners - GENESIS Biomed
SEDE ORYZON
ORYZON reports financial results and corporate update for quarter ended September 30, 2025
Healthcare · Financing
The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following…
Partners - Oryzon Genomics
Sede en Bruselas de la Comisión Europea
AseBio participates in the public consultation of the upcoming Biotech Act with proposals to boost European biotechnology
Healthcare · Industrial biotechnology · International · Financing
Harmonizing regulation, improving access to funding and talent, advancing biomanufacturing and…
Entrega de los Premios Nacionales de Innovación y de Diseño 2024 a BIOLAN
BIOLAN awarded the 2024 National Innovation Prize, presented by queen Letizia
Talento
The Bizkaia-based biotechnology company received the award at the Royal Palace of El Pardo (Madrid…
Partners - Biolan
Gonzalo Casino, Director General Cencora Pharmalex Iberia
#NewAseBioMember | "AseBio is a meeting point for the sector and a platform for the Spanish biotechnology industry"
Healthcare · Corporate
Meet our new member Cencora Pharmalex. We spoke with Gonzalo Casino Fernández, Director General…
AseBio - PHARMALEZ SPAIN S.L.U
20251009 TOVX October Medical Meetings-Spanish
Theriva™ Biologics anuncia varias presentaciones en congresos médicos
Access to innovation
VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 
Partners - THERIVA BIOLOGICS S.L.
PreClin VCN-12 Data@ESGCT
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Healthcare
Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a…
Partners - THERIVA BIOLOGICS S.L.
Sede Natac
Natac records revenues of €31.88 million through mid-October
Healthcare
The company expects to close the year with sales exceeding €50 million and an EBITDA above €20…
Partners - Natac Group
Asabys co-lidera la Series B de Qida de €37M
Qida raises €37 million to continue improving the quality of life of the senior segment at home
Financing
The investment will enable Qida to boost growth, technological innovation, and the attraction of…
Partners - Asabys Partners